We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$982M
AUM Growth
+$92.9M
Cap. Flow
+$134M
Cap. Flow %
13.65%
Top 10 Hldgs %
4.69%
Holding
1,940
New
653
Increased
414
Reduced
285
Closed
576

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$4.61M
2
DPZ icon
Domino's
DPZ
+$3.96M
3
BRKR icon
Bruker
BRKR
+$3.65M
4
TJX icon
TJX Companies
TJX
+$3.62M
5
SBUX icon
Starbucks
SBUX
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Industrials 16.2%
3 Technology 12.7%
4 Financials 11.7%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVA icon
201
Avista
AVA
$3.22B
$1.25M 0.13%
+32,035
New +$1.34M
MGRC icon
202
McGrath RentCorp
MGRC
$2.97B
$1.25M 0.13%
17,363
-353
-2% -$25.9K
TRI icon
203
Thomson Reuters
TRI
$43.7B
$1.24M 0.13%
10,679
-5,974
-36% -$696K
VIR icon
204
Vir Biotechnology
VIR
$1.48B
$1.24M 0.13%
28,533
+23,032
+419% +$997K
PNFP icon
205
Pinnacle Financial Partners Inc
PNFP
$16.1B
$1.24M 0.13%
+13,191
New +$1.21M
HHH icon
206
Howard Hughes
HHH
$4.06B
$1.24M 0.13%
+14,812
New +$1.28M
CNCE
207
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1.24M 0.13%
379,244
+98,635
+35% +$346K
CXT icon
208
Crane NXT
CXT
$3.13B
$1.24M 0.13%
37,611
+10,145
+37% +$338K
DORM icon
209
Dorman Products
DORM
$4.08B
$1.23M 0.13%
13,032
+10,211
+362% +$1.01M
PARA
210
DELISTED
Paramount Global Class B
PARA
$1.23M 0.13%
31,159
-8,826
-22% -$360K
ENVA icon
211
Enova International
ENVA
$6.37B
$1.23M 0.13%
35,594
+6,022
+20% +$196K
WBS icon
212
Webster Financial
WBS
$12.8B
$1.23M 0.13%
22,561
+11,869
+111% +$591K
ENLC
213
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$1.23M 0.13%
180,272
-26,153
-13% -$153K
CMRX
214
DELISTED
Chimerix, Inc.
CMRX
$1.22M 0.12%
197,693
+152,547
+338% +$1.05M
ABT icon
215
Abbott
ABT
$187B
$1.22M 0.12%
+10,345
New +$1.27M
EXPO icon
216
Exponent
EXPO
$3.21B
$1.22M 0.12%
10,803
-13,519
-56% -$1.46M
VEON icon
217
VEON
VEON
$3.87B
$1.21M 0.12%
23,299
+11,442
+96% +$550K
TACO
218
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$1.21M 0.12%
138,479
-12,485
-8% -$111K
ROL icon
219
Rollins
ROL
$17.7B
$1.21M 0.12%
+34,190
New +$1.28M
MO icon
220
Altria Group
MO
$113B
$1.21M 0.12%
+26,469
New +$1.28M
VSH icon
221
Vishay Intertechnology
VSH
$5.03B
$1.2M 0.12%
59,923
-29,370
-33% -$635K
NOAH
222
Noah Holdings
NOAH
$594M
$1.2M 0.12%
+32,402
New +$1.28M
TSLA icon
223
Tesla
TSLA
$1.26T
$1.2M 0.12%
4,650
-3,360
-42% -$791K
ACCO icon
224
Acco Brands
ACCO
$407M
$1.2M 0.12%
139,127
+27,822
+25% +$245K
SNDR icon
225
Schneider National
SNDR
$6.17B
$1.2M 0.12%
52,534
+41,396
+372% +$915K

Similar funds

GSA Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, GSA Capital Partners held 1,940 positions worth $982M, up 10% from $889M the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

GSA Capital Partners deployed $134M of net new capital in Q3 2021, opening 653 new positions and adding to 414 existing holdings. Its largest new stake was Openlane: 280,405 shares worth $4.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Amazon, an estimated $4.61M trimmed.

  • GSA Capital Partners's largest Q3 2021 buy was Openlane: 280,405 shares worth $4.6M.
  • GSA Capital Partners added most to BridgeBio Pharma in Q3 2021, an estimated $4.54M increase.
  • GSA Capital Partners's biggest Q3 2021 reduction was Amazon, cutting an estimated $4.61M.
  • GSA Capital Partners fully exited TJX Companies in Q3 2021, selling an estimated $3.62M.
  • GSA Capital Partners's ten largest holdings make up 4.7% of its $982M portfolio in Q3 2021.
  • GSA Capital Partners opened 653 new positions and closed 576 in Q3 2021.
  • GSA Capital Partners's portfolio value rose 10% quarter-over-quarter to $982M.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.